A STRATEGY FOR DEVELOPING NEW TREATMENT PARADIGMS FOR NEUROPSYCHIATRIC AND NEUROCOGNITIVE SYMPTOMS IN ALZHEIMER’S DISEASE

A STRATEGY FOR DEVELOPING NEW TREATMENT PARADIGMS FOR NEUROPSYCHIATRIC AND NEUROCOGNITIVE SYMPTOMS IN ALZHEIMER’S DISEASE

Successful disease-modifying drug development for Alzheimer’s disease has hit a roadblock with the recent failures of amyloid-based therapies, highlighting the translational disconnect between preclinical animal models and clinical outcome. Although disease-modifying therapies are the Holy Grail to...

Full description

Bibliographic Details
Main Authors: Hugo eGeerts, Athan eSpiros, Patrick eRoberts, Robert eCarr
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-04-01
Series:Frontiers in Pharmacology
Subjects:
Alzheimer Disease
Apathy
Cognition
Computer Simulation
Drug Discovery
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2013.00047/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fphar.2013.00047/full

Similar Items